(1) All health benefit plans, as defined in ORS 743B.005, shall include coverage of the treatment of perimenopause, menopause and postmenopause, including but not limited to the following:
- (a) Hormone therapy including combination estrogen and hormone medicines, combination estrogen and progesterone medicines and estrogen-only medicines;
- (b) SSRIs and SNRIs;
- (c) Vaginal estrogen;
- (d) Medications to prevent or treat osteoporosis;
- (e) Neurokinin B antagonists;
- (f) Topical hormone therapy; and
- (g) Bioidentical hormones.
- (2) The coverage required in this section is limited to drugs that have been approved by the United States Food and Drug Administration.
- (3) This section is exempt from ORS 743A.001.
Note: 743A.114 was added to and made a part of the Insurance Code by legislative action but was not added to ORS chapter 743A or any series therein. See Preface to Oregon Revised Statutes for further explanation.
[2025 c.500 §2]